Nosaka K - Search Results

1

Heat Shock Protein 105 as an Immunotherapeutic Target for Patients With Cervical Cancer.

Nosaka K, Suzuki S, Yoshikawa T, Shimomura M, Kitami K, Yoshida K, Yoshihara M, Kikkawa F, Nakatsura T, Kajiyama H. Nosaka K, et al. Anticancer Res. 2021 Oct;41(10):4741-4751. doi: 10.21873/anticanres.15289. Anticancer Res. 2021. PMID: 34593423

2

Heat shock protein 105 peptide vaccine could induce antitumor immune reactions in a phase I clinical trial.

Shimizu Y, Yoshikawa T, Kojima T, Shoda K, Nosaka K, Mizuno S, Wada S, Fujimoto Y, Sasada T, Kohashi K, Bando H, Endo I, Nakatsura T. Shimizu Y, et al. Among authors: nosaka k. Cancer Sci. 2019 Oct;110(10):3049-3060. doi: 10.1111/cas.14165. Epub 2019 Sep 19. Cancer Sci. 2019. PMID: 31390678 Free PMC article. Clinical Trial.

3

Efficacy of immunotherapy targeting the neoantigen derived from epidermal growth factor receptor T790M/C797S mutation in non-small cell lung cancer.

Akazawa Y, Saito Y, Yoshikawa T, Saito K, Nosaka K, Shimomura M, Mizuno S, Nakamoto Y, Nakatsura T. Akazawa Y, et al. Among authors: nosaka k. Cancer Sci. 2020 Aug;111(8):2736-2746. doi: 10.1111/cas.14451. Epub 2020 Jun 18. Cancer Sci. 2020. PMID: 32391625 Free PMC article.

4

Feasibility and benefit of concurrent chemoradiotherapy for elderly patients with uterine cervical cancer.

Nosaka K, Shibata K, Utsumi F, Yoshida K, Niimi K, Sekiya R, Suzuki S, Kajiyama H, Kikkawa F. Nosaka K, et al. Tumori. 2016 Dec 1;102(6):600-605. doi: 10.5301/tj.5000530. Epub 2016 Jul 19. Tumori. 2016. PMID: 27443893

5

Phase I study of glypican-3-derived peptide vaccine therapy for patients with refractory pediatric solid tumors.

Tsuchiya N, Hosono A, Yoshikawa T, Shoda K, Nosaka K, Shimomura M, Hara J, Nitani C, Manabe A, Yoshihara H, Hosoya Y, Kaneda H, Kinoshita Y, Kohashi K, Yoshimura K, Fujinami N, Saito K, Mizuno S, Nakatsura T. Tsuchiya N, et al. Among authors: nosaka k. Oncoimmunology. 2017 Sep 27;7(1):e1377872. doi: 10.1080/2162402X.2017.1377872. eCollection 2017. Oncoimmunology. 2017. PMID: 29296538 Free PMC article.

6

Suppression of lung and liver carcinogenesis in mice by oral administration of myo-inositol.

Nishino H, Murakoshi M, Masuda M, Tokuda H, Satomi Y, Onozuka M, Yamaguchi S, Bu P, Tsuruta A, Nosaka K, Baba M, Takasuka N. Nishino H, et al. Among authors: nosaka k. Anticancer Res. 1999 Sep-Oct;19(5A):3663-4. Anticancer Res. 1999. PMID: 10625935

7

Steady-state kinetics and mutational studies of recombinant human thiamin pyrophosphokinase.

Onozuka M, Nosaka K. Onozuka M, et al. Among authors: nosaka k. J Nutr Sci Vitaminol (Tokyo). 2003 Jun;49(3):156-62. doi: 10.3177/jnsv.49.156. J Nutr Sci Vitaminol (Tokyo). 2003. PMID: 12953792

8

Association of nucleoside diphosphate kinase nm23-H2 with human telomeres.

Nosaka K, Kawahara M, Masuda M, Satomi Y, Nishino H. Nosaka K, et al. Biochem Biophys Res Commun. 1998 Feb 13;243(2):342-8. doi: 10.1006/bbrc.1997.8097. Biochem Biophys Res Commun. 1998. PMID: 9480811

9

Molecular cloning and expression of a mouse thiamin pyrophosphokinase cDNA.

Nosaka K, Onozuka M, Nishino H, Nishimura H, Kawasaki Y, Ueyama H. Nosaka K, et al. J Biol Chem. 1999 Nov 26;274(48):34129-33. doi: 10.1074/jbc.274.48.34129. J Biol Chem. 1999. PMID: 10567383 Free article.

10

Molecular cloning and analysis of the 5'-flanking region of the human thiamin pyrophosphokinase gene.

Onozuka M, Konno H, Akaji K, Nishino H, Nosaka K. Onozuka M, et al. Among authors: nosaka k. J Nutr Sci Vitaminol (Tokyo). 2005 Aug;51(4):274-7. doi: 10.3177/jnsv.51.274. J Nutr Sci Vitaminol (Tokyo). 2005. PMID: 16262001

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

658 results

Search Page

Filters